Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Inolitazone

Inolitazone
Inolitazone (RS5444) a high-affinity PPARγ agonist. Inolitazone exhibits IC50 for growth inhibition is ~0.8 nM in vitro.
Catalog No. T15581Cas No. 223132-37-4
Select Batch
Purity:99.58%
Contact us for more batch information
Resource Download

Inolitazone

Catalog No. T15581Cas No. 223132-37-4
Inolitazone (RS5444) a high-affinity PPARγ agonist. Inolitazone exhibits IC50 for growth inhibition is ~0.8 nM in vitro.
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
Pack SizePriceAvailabilityQuantity
1 mg$67In Stock
5 mg$160In Stock
10 mg$256In Stock
25 mg$415In Stock
50 mg$592In Stock
100 mg$793In Stock
500 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$198In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Inolitazone"

Product Introduction

Bioactivity
Description
Inolitazone (RS5444) a high-affinity PPARγ agonist. Inolitazone exhibits IC50 for growth inhibition is ~0.8 nM in vitro.
In vitro
Inolitazone (10 nM) inhibits the growth of DRO cells through a PPARγ-dependent mechanism[1]. Inolitazone upregulates the cell cycle kinase inhibitor, p21WAF1/CIP1. Inolitazone (10 nM) activates PPARγ:RXRα-dependent transcription utilizing a PPRE response element fused to a luciferase reporter gene (PPRE3-tk-luc). Inolitazone specifically activates PPARγ, but not PPARα or PPARδ. Inolitazone (10 nM) following transient transfection with the appropriate PPAR isoform (γ, α, or δ) and PPAR response element linked to a luciferase reporter in RIE rat small intestinal cell line, which does not express PPARs, yields increased luciferase activity only in the presence of PPARγ and PPRE3-tk-luc[2].
In vivo
In athymic nude mice prior to DRO tumor cell implantation, Inolitazone inhibits tumor growth in a dose responsive fashion. 0.025% Inolitazone inhibits growth on day 32 by 94.4%. In the 0.0025% treatment group, tumor growth is inhibited by 62.3% while the 0.00025% dose demonstrated no growth inhibitory activity as compared to control. Inolitazone treated animals demonstrate tumor growth inhibition of 68.9% in DRO tumors and 48.3% in ARO tumors on day 35. Inolitazone plus Paclitaxel demonstrate additive antiproliferative activity in cell culture and minimal ATC tumor growth[1].
AliasRS5444, Efatutazone, CS-7017
Chemical Properties
Molecular Weight502.58
FormulaC27H26N4O4S
Cas No.223132-37-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (109.43 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9897 mL9.9487 mL19.8973 mL99.4866 mL
5 mM0.3979 mL1.9897 mL3.9795 mL19.8973 mL
10 mM0.1990 mL0.9949 mL1.9897 mL9.9487 mL
20 mM0.0995 mL0.4974 mL0.9949 mL4.9743 mL
50 mM0.0398 mL0.1990 mL0.3979 mL1.9897 mL
100 mM0.0199 mL0.0995 mL0.1990 mL0.9949 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Inolitazone | purchase Inolitazone | Inolitazone cost | order Inolitazone | Inolitazone chemical structure | Inolitazone in vivo | Inolitazone in vitro | Inolitazone formula | Inolitazone molecular weight